C. Kallenberg

发表

The impact factor of rheumatology journals: an analysis of 2008 and the recent 10 years

Min Chen, Ming‐hui Zhao, C. Kallenberg, 2010, Rheumatology International.

Apoptosis in Human Skin: Role in Pathogenesis of Various Diseases and Relevance for Therapy

C. Kallenberg, E. Reefman, P. Limburg, 2005, Annals of the New York Academy of Sciences.

Inhibition of proinflammatory genes in anti-GBM glomerulonephritis by targeted dexamethasone-loaded AbEsel liposomes.

C. Kallenberg, J. Kamps, G. Molema, 2008, American journal of physiology. Renal physiology.

Systems biology analysis of Sjögren's syndrome and mucosa-associated lymphoid tissue lymphoma in parotid glands.

A. Vissink, S. Horvath, C. Kallenberg, 2009, Arthritis and rheumatism.

Parotid sialography for diagnosing Sjögren syndrome.

A. Vissink, J. Roodenburg, C. Kallenberg, 2002, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

Progression of salivary gland dysfunction in patients with Sjögren’s syndrome

A. Vissink, C. Kallenberg, F. Spijkervet, 2006, Annals of the rheumatic diseases.

Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome.

A. Vissink, C. Kallenberg, D. Elashoff, 2007, Arthritis and rheumatism.

Preclinical validation of salivary biomarkers for primary Sjögren's syndrome

A. Vissink, C. Kallenberg, Lei Zhang, 2010, Arthritis care & research.

Identification of autoantibody biomarkers for primary Sjögren's syndrome using protein microarrays

A. Vissink, C. Kallenberg, Hui Zhou, 2011, Proteomics.

Transancestral mapping and genetic load in systemic lupus erythematosus

P. Gregersen, J. Rioux, P. Gaffney, 2017, Nature Communications.

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2013, The New England journal of medicine.

European therapeutic trials in ANCA‐associated systemic vasculitis: disease scoring, consensus regimens and proposed clinical trials EUROPEAN COMMUNITY STUDY GROUP ON CLINICAL TRIALS IN SYSTEMIC VASCULITIS ECSYSVASTRIAL (BMHl‐Cr93‐1078)

C. Kallenberg, C. Feighery, D. Abramowicz, 1995, Clinical and experimental immunology.

Antiproteinase 3- and antimyeloperoxidase-associated vasculitis.

R. Gans, C. Kallenberg, P. D. de Jong, 2000, Kidney international.

Staphylococcus aureus and Wegener's granulomatosis

C. Kallenberg, E. Popa, C. Stegeman, 2001, Arthritis research.

Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.

C. Kallenberg, J. Damoiseaux, M. Patnaik, 2003, Journal of immunological methods.

Functional defect of circulating regulatory CD4+ T cells in patients with Wegener's granulomatosis in remission.

C. Kallenberg, P. Limburg, W. Abdulahad, 2007, Arthritis and rheumatism.

Rats and mice immunised with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes

C. Kallenberg, P. Limburg, P. Heeringa, 2007, Annals of the rheumatic diseases.

Influenza vaccination does not result in an increase in relapses in patients with ANCA-associated vasculitis.

C. Kallenberg, P. Stassen, C. Stegeman, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Retinoid X receptor beta polymorphisms do not explain functional differences in vitamins D and A response in Antineutrophil cytoplasmic antibody associated vasculitis patients

C. Kallenberg, P. Heeringa, B. Yard, 2009, Autoimmunity.

ANCA-negative pauci-immune crescentic glomerulonephritis

Min Chen, Ming‐hui Zhao, C. Kallenberg, 2009, Nature Reviews Nephrology.

T-helper cells as new players in ANCA-associated vasculitides

C. Kallenberg, P. Lamprecht, W. Abdulahad, 2011, Arthritis research & therapy.

High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Kenneth G. C. Smith, C. Kallenberg, P. Lyons, 2012, Journal of the American Society of Nephrology : JASN.

Extended versus standard azathioprine maintenance therapy in newly diagnosed proteinase-3 anti-neutrophil cytoplasmic antibody-associated vasculitis patients who remain cytoplasmic anti-neutrophil cytoplasmic antibody-positive after induction of remission: a randomized clinical trial.

C. Kallenberg, P. van Paassen, A. Voskuyl, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Association of Serum Calprotectin (S100A8/A9) Level With Disease Relapse in Proteinase 3–Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

P. Merkel, J. Stone, C. Kallenberg, 2016, Arthritis & rheumatology.

Ig Gene Analysis Reveals Altered Selective Pressures on Ig-Producing Cells in Parotid Glands of Primary Sjögren’s Syndrome Patients

A. Vissink, Uri Hershberg, C. Kallenberg, 2015, The Journal of Immunology.

Glands of Primary Sjögren's Syndrome Pressures on Ig-Producing Cells in Parotid Ig Gene Analysis Reveals Altered Selective

A. Vissink, Uri Hershberg, C. Kallenberg, 2015 .

Persistence of immunoglobulin-producing cells in parotid salivary glands of patients with primary Sjögren's syndrome after B cell depletion therapy

A. Vissink, C. Kallenberg, F. Spijkervet, 2012, Annals of the rheumatic diseases.

Fcgamma receptor gene polymorphisms in Japanese patients with systemic lupus erythematosus: contribution of FCGR2B to genetic susceptibility.

C. Kallenberg, K. Tokunaga, H. Hashimoto, 2002, Arthritis and rheumatism.

Late breaking clinical trials 1

P. Raskin, J. Stone, C. Kallenberg, 2011 .

Increase in IL-21 producing T-cells in patients with systemic lupus erythematosus

C. Kallenberg, P. Limburg, M. Bijl, 2011, Arthritis research & therapy.

Accelerated Atherosclerosis in Patients with Systemic Autoimmune Diseases

C. Kallenberg, M. Bijl, K. Leeuw, 2005, Annals of the New York Academy of Sciences.

Selective elimination of pathogenic synovial fluid T-cells from rheumatoid arthritis and juvenile idiopathic arthritis by targeted activation of Fas-apoptotic signaling.

C. Kallenberg, H. Wajant, W. Armbrust, 2011, Immunology letters.

EASI—The European Autoimmunity Standardisation Initiative

C. Kallenberg, J. Piette, A. Wiik, 2007, Annals of the New York Academy of Sciences.

Monocyte activation in patients with Wegener’s granulomatosis

C. Kallenberg, J. Tervaert, A. Kobold, 1999, Annals of the rheumatic diseases.

Refractory disease in antineutrophil cytoplasmic antibodies associated vasculitis

C. Kallenberg, A. Rutgers, 2012, Current opinion in rheumatology.

Chapter 11 Neurobiology of Tourette ’ s syndrome : do immune factors really matter ?

C. Kallenberg, P. Hoekstra, R. Minderaa, 2018 .

Evaluation of capture ELISA for detection of antineutrophil cytoplasmic antibodies directed against proteinase 3 in Wegener's granulomatosis: first results from a multicentre study.

C. Kallenberg, J. Willem, P. Limburg, 2003, Rheumatology.

Chapter 5 Native and recombinant proteins to analyze autoantibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis

C. Kallenberg, P. Limburg, C. Stegeman, 2017 .

Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis

C. Kallenberg, J. Savige, D. Blockmans, 2017, Nature Reviews Rheumatology.

Pathogenetic and clinical aspects of ANCA-associated vasculitis

C. Kallenberg, 2017 .

University of Groningen Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis Bossuyt,

C. Kallenberg, J. Savige, D. Blockmans, 2017 .

The association of serum calprotectin ( S 100 A 8 / S 100 A 9 ) levels with disease relapses in PR 3-ANCA-associated vasculitis

P. Merkel, J. Stone, C. Kallenberg, 2016 .

Design of the Rituximab in ANCA-Associated Vasculitis (RAVE) Trial

P. Merkel, J. Stone, C. Kallenberg, 2011 .

Pulmonary-Renal Syndrome with a Focus on Anti-GBM Disease

C. Kallenberg, C. Stegeman, J. Sanders, 2011, Seminars in respiratory and critical care medicine.

Pathogenesis of ANCA-associated vasculitides

C. Kallenberg, 2011, Annals of the rheumatic diseases.

Pauci-immune necrotizing glomerulonephritis.

C. Kallenberg, C. Stegeman, J. Sanders, 2010, Rheumatic diseases clinics of North America.

New advances in the pathogenesis of ANCA-associated vasculitides.

C. Kallenberg, M. Chen, 2009, Clinical and Experimental Rheumatology.

The Last Classification of Vasculitis

C. Kallenberg, 2008, Clinical reviews in allergy & immunology.

13 – ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES WITH SPECIFICITY FOR MYELOPEROXIDASE

C. Kallenberg, 2007 .

Chapter 7 ANCA-Associated Systemic Vasculitides: Mechanisms

C. Kallenberg, 2007 .

Mechanisms of Disease: pathogenesis and treatment of ANCA-associated vasculitides

C. Kallenberg, P. Heeringa, C. Stegeman, 2006, Nature Clinical Practice Rheumatology.

Quantitation of Autoantibodies in Systemic Autoimmune Diseases: Clinically Useful?

C. Kallenberg, P. Limburg, M. Bijl, 2006, Lupus.

Systemic vasculitides, an introduction

C. Kallenberg, J. Tervaert, 2001 .

Disease-modifying Therapy in Vasculitides

C. Kallenberg, J. Tervaert, 2012, Progress in Inflammation Research.

What is new with anti-neutrophil cytoplasmic antibodies: diagnostic, pathogenetic and therapeutic implications.

C. Kallenberg, J. Tervaert, 1999, Current opinion in nephrology and hypertension.

AGE and their receptor RAGE in systemic autoimmune diseases: An inflammation propagating factor contributing to accelerated atherosclerosis

A. Smit, C. Kallenberg, P. Limburg, 2009, Autoimmunity.

Response to ‘T-helper 17 cell cytokines and interferon type I: partners in crime in systemic lupus erythematosus?’

C. Kallenberg, W. Abdulahad, S. Dolff, 2014, Arthritis Research & Therapy.

Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2016, Analytical chemistry.

CYCLOPHOSPHAMIDE AND SUPPRESSOR CELL FUNCTION

C. Kallenberg, 1981, The Lancet.

Circulating Angiopoietin-2 as a Biomarker in ANCA-Associated Vasculitis

J. Krischer, P. Merkel, J. Stone, 2012, PloS one.

High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins

C. Kallenberg, M. Bijl, J. Westra, 2015, Arthritis Research & Therapy.

Hypoxia inducible factor-1-alpha ( HIF-1 alpha ) is related to both angiogenesis and inflammation in rheumatoid arthritis

C. Kallenberg, A. L. Boerboom, P. Limburg, 2018 .

University of Groningen Hypoxia inducible factor-1-alpha ( HIF-1 alpha ) is related to both angiogenesis and inflammation in rheumatoid arthritis

C. Kallenberg, A. L. Boerboom, P. Limburg, 2017 .

Hypoxia inducible factor-1-alpha (HIF-1alpha) is related to both angiogenesis and inflammation in rheumatoid arthritis.

C. Kallenberg, M. V. van Leeuwen, A. L. Boerboom, 2009, Clinical and experimental rheumatology.

Hypoxia inducible factor-1-alpha (HIF-1α) is related to both angiogenesis and inflammation in rheumatoid arthritis

C. Kallenberg, A. L. Boerboom, P. Limburg, 2006 .

Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis

M. V. van Dijk, C. Kallenberg, P. Limburg, 2013, Arthritis Research & Therapy.

Disturbed Th1, Th2, Th17 and T(reg) balance in patients with systemic lupus erythematosus.

C. Kallenberg, P. Limburg, M. Bijl, 2011, Clinical immunology.

Urinary T cells in active lupus nephritis show an effector memory phenotype

M. V. van Dijk, C. Kallenberg, P. Limburg, 2010, Annals of the rheumatic diseases.

Coexpression of CD177 and membrane proteinase 3 on neutrophils in antineutrophil cytoplasmic autoantibody-associated systemic vasculitis: anti-proteinase 3-mediated neutrophil activation is independent of the role of CD177-expressing neutrophils.

C. Kallenberg, P. Limburg, M. Bijl, 2009, Arthritis and rheumatism.

Prognostic Value of Renal Hemodynamic Characteristics in Patients with Proliferative Lupus Nephritis

C. Kallenberg, M. Bijl, H. Martens, 2007, Kidney and Blood Pressure Research.

Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controls

C. Kallenberg, M. V. van Leeuwen, P. Limburg, 2007, Annals of the rheumatic diseases.

Opsonization of late apoptotic cells by systemic lupus erythematosus (SLE) autoantibodies inhibits their uptake via an Fc gamma R-dependent mechanism

C. Kallenberg, E. Reefman, P. Limburg, 2007 .

Opsonization of late apoptotic cells by systemic lupus erythematosus autoantibodies inhibits their uptake via an Fcgamma receptor-dependent mechanism.

C. Kallenberg, E. Reefman, P. Limburg, 2007, Arthritis and rheumatism.

Ultraviolet light and cutaneous lupus

C. Kallenberg, M. Bijl, 2006, Lupus.

Recombinant protein to analyze autoantibodies to proteinase 3 in systemic vasculitis.

C. Kallenberg, P. Limburg, C. Stegeman, 2003, American journal of clinical pathology.

Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis

Caroline Gordon, John P A Ioannidis, Jürgen Floege, 2012, Annals of the rheumatic diseases.

Pro: Cyclophosphamide in lupus nephritis.

C. Kallenberg, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Could we abandon cyclophosphamide in systemic vasculitis and lupus nephritis?

C. Kallenberg, 2012, Annals of the rheumatic diseases.

Prevention of relapsing disease in anti-neutrophil cytoplasmic antibody related necrotizing small-vessel vasculitis: the role for autoantibody guided and anti-bacterial treatment

C. Kallenberg, C. Stegeman, J. Tervaert, 2001 .

Treatment of ANCA-Associated Vasculitis, Where to Go?

C. Kallenberg, 2012, Clinical Reviews in Allergy & Immunology.

ANCA-associated vasculitides—advances in pathogenesis and treatment

Min Chen, C. Kallenberg, 2010, Nature Reviews Rheumatology.

154 – Biology and immunopathogenesis of vasculitis

C. Kallenberg, 2015 .

Treatment of Mucosa-associated Lymphoid Tissue Lymphoma in Sjögren’s Syndrome: A Retrospective Clinical Study

A. Vissink, J. Roodenburg, C. Kallenberg, 2011, The Journal of Rheumatology.

Renal expression of endothelial and inducible nitric oxide synthase, and formation of peroxynitrite‐modified proteins and reactive oxygen species in Wegener's granulomatosis

C. Kallenberg, M. Bijl, P. Heeringa, 2001, The Journal of pathology.

What is the evidence for prophylactic antibiotic treatment in patients with systemic vasculitides?

C. Kallenberg, 2011, Current opinion in rheumatology.

Anti‐neutrophil cytoplasmic antibody (ANCA)‐associated vasculitis: where to go?

C. Kallenberg, 2011, Clinical and experimental immunology.

Abundance of the long pentraxin PTX3 at sites of leukocytoclastic lesions in patients with small-vessel vasculitis.

C. Kallenberg, P. Limburg, M. Jonkman, 2006, Arthritis and rheumatism.

9 Laboratory findings in the vasculitides

C. Kallenberg, 1997 .

Anti-Neutrophil Cytoplasmic Antibodies (ANCA): New Tools in the Diagnosis and Follow-Up of Necrotizing Glomerulonephritis and Vasculitis

C. Kallenberg, J. Tervaert, 1991 .

Bronchoalveolar lavage cell analysis and lung function impairment in patients with systemic lupus erythematosus (SLE)

D. Postma, C. Kallenberg, H. Bootsma, 1993, Clinical and experimental immunology.

Pulmonary function in systemic lupus erythematosus is related to distinct clinical, serologic, and nailfold capillary patterns.

D. Postma, C. Kallenberg, T. W. van der Mark, 1992, The American journal of medicine.

Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud's phenomenon with and without an underlying connective tissue disease.

C. Kallenberg, H. Groen, G. Wichers, 1990, The American journal of medicine.

Expression and regulation of HIF-1alpha in macrophages under inflammatory conditions; significant reduction of VEGF by CaMKII inhibitor

C. Kallenberg, M. V. van Leeuwen, J. Westra, 2010, BMC musculoskeletal disorders.

Regulation of Cytokine‐Induced HIF‐1α Expression in Rheumatoid Synovial Fibroblasts

C. Kallenberg, P. Limburg, J. Westra, 2007, Annals of the New York Academy of Sciences.

The complement system in systemic autoimmune disease.

Min Chen, C. Kallenberg, M. Daha, 2010, Journal of autoimmunity.

Complement system activation in ANCA vasculitis: A translational success story?

C. Kallenberg, P. Heeringa, 2015, Molecular immunology.

Novel territory for neutrophils in the pathogenesis of ANCA-associated vasculitides.

Min Chen, C. Kallenberg, 2009, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Complement Activation Is Involved in Renal Damage in Human Antineutrophil Cytoplasmic Autoantibody Associated Pauci-Immune Vasculitis

Min Chen, C. Kallenberg, P. Heeringa, 2009, Journal of Clinical Immunology.

Pathophysiology of ANCA-Associated Small Vessel Vasculitis

C. Kallenberg, 2010, Current rheumatology reports.

CD4‐Positive Effector Memory T Cells Participate in Disease Expression in ANCA‐Associated Vasculitis

C. Kallenberg, P. Limburg, W. Abdulahad, 2007, Annals of the New York Academy of Sciences.

The predictive value of fluctuations in IgM and IgG class anti-dsDNA antibodies for relapses in systemic lupus erythematosus. A prospective long term observation

C. Kallenberg, P. Limburg, H. Bootsma, 1997, Annals of the rheumatic diseases.

Use of mycophenolic acid in non-transplant renal diseases.

C. Kallenberg, P. Stassen, C. Stegeman, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Churg-Strauss syndrome: just one disease entity?

C. Kallenberg, 2005, Arthritis and rheumatism.

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.

P. Merkel, C. Kallenberg, E. Matteson, 2011, Journal of the American Society of Nephrology.

Usefulness of antineutrophil cytoplasmic autoantibodies in diagnosing and managing systemic vasculitis.

C. Kallenberg, 2016, Current opinion in rheumatology.

Review article: The role of CD4+ T cells in ANCA‐associated systemic vasculitis

C. Kallenberg, W. Abdulahad, C. Stegeman, 2009, Nephrology.

Antineutrophil cytoplasmic autoantibody-associated small-vessel vasculitis

C. Kallenberg, 2007, Current opinion in rheumatology.

Opponent's comments.

C. Kallenberg, 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Urinary CD4+ effector memory T cells reflect renal disease activity in antineutrophil cytoplasmic antibody-associated vasculitis.

C. Kallenberg, P. Limburg, W. Abdulahad, 2009, Arthritis and rheumatism.

Association of Pulmonary Hemorrhage, Positive Proteinase 3, and Urinary Red Blood Cell Casts With Venous Thromboembolism in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

P. Merkel, J. Stone, C. Kallenberg, 2019, Arthritis & rheumatology.

Towards precision medicine in ANCA-associated vasculitis.

C. Kallenberg, P. Heeringa, A. Boots, 2018, Rheumatology.

Pathogenesis and treatment of ANCA-associated vasculitides.

C. Kallenberg, 2015, Clinical and experimental rheumatology.

B-cell therapy in antineutrophil cytoplasmic antibody-associated vasculitis.

C. Kallenberg, T. Hauser, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Clinical immunology--autoimmunity in the Netherlands.

C. Kallenberg, J. Tervaert, 2014, Immunology letters.

C URRENT OPINION Is B-cell depletion first choice in antineutrophil cytoplasmic antibody-associated vasculitis?

C. Kallenberg, 2014 .

Pathogenesis of ANCA-associated vasculitis: new possibilities for intervention.

C. Kallenberg, P. Heeringa, W. Abdulahad, 2013, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Autoantibodies and Vascular Inflammation

C. Kallenberg, J. Tervaert, J. Sanders, 2012 .

Pathogenesis of ANCA-Associated Vasculitis, an Update

C. Kallenberg, 2011, Clinical reviews in allergy & immunology.

Treatment of primary Sjögren's syndrome with anti-CD20 therapy (rituximab). A feasible approach or just a starting point?

A. Vissink, C. Kallenberg, H. Bootsma, 2011, Expert opinion on biological therapy.

Re-Occurring Proteinuria in a SLE Patient: Always Lupus Nephritis?

C. Kallenberg, M. Bijl, M. C. V. D. Heuvel, 2017 .

Granuloma formation in ANCA‐associated vasculitides

C. Kallenberg, J. Epplen, S. Wieczorek, 2009, APMIS. Supplementum.

HLA-DR4, DR13(6) and the ancestral haplotype A1B8DR3 are associated with ANCA-associated vasculitis and Wegener's granulomatosis.

C. Kallenberg, P. Stassen, C. Stegeman, 2009, Rheumatology.

HLA-DR 4 , DR 13 ( 6 ) and the ancestral haplotype A 1 B 8 DR 3 are associated with ANCA-associated vasculitis and Wegener ’ s granulomatosis

C. Kallenberg, P. Stassen, C. Stegeman, 2009 .

Cellular immunity in Wegener's granulomatosis: characterizing T lymphocytes.

C. Kallenberg, Emile de Heer, B. Yard, 2009, Arthritis and rheumatism.

Disease Activity, Antineutrophil Cytoplasmic Antibody Type, and Lipid Levels in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

P. Merkel, J. Stone, C. Kallenberg, 2019, Arthritis & rheumatology.

Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

D. Schroeder, P. Merkel, J. Stone, 2018 .

Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

D. Schroeder, P. Merkel, J. Stone, 2018, Arthritis & rheumatology.

Myeloperoxidase–Antineutrophil Cytoplasmic Antibody (ANCA)–Positive and ANCA‐Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets

P. Merkel, J. Stone, C. Kallenberg, 2016, Arthritis & rheumatology.

Full Review B-cell therapy in antineutrophil cytoplasmic antibody-associated vasculitis

C. Kallenberg, T. Hauser, 2015 .

University of Groningen Low anti-staphylococcal IgG responses in granulomatosis with polyangiitis patients despite long-term Staphylococcus aureus exposure Glasner,

Jan Maarten van Dijl, C. Kallenberg, P. Heeringa, 2015 .

The diagnosis and classification of microscopic polyangiitis.

C. Kallenberg, 2014, Journal of autoimmunity.

Chapter 12 – Antineutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase

C. Kallenberg, 2014 .

Renal vasculitis in 2012: Reclassification and the introduction of biologicals

C. Kallenberg, 2013, Nature Reviews Nephrology.

Etiopathogenesis of systemic autoimmune diseases.

C. Kallenberg, 2013, Current opinion in rheumatology.

Neutrophil membrane expression of proteinase 3 (PR3) is related to relapse in PR3-ANCA-associated vasculitis.

C. Kallenberg, P. Limburg, C. Stegeman, 2002, Journal of the American Society of Nephrology : JASN.

Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis.

P. Merkel, C. Kallenberg, E. Matteson, 2011, Arthritis and rheumatism.

Why rheumatologists should be involved in the treatment of lupus nephritis

C. Kallenberg, M. Bijl, 2008, Nature Clinical Practice Nephrology.

New insights into the pathogenesis of antineutrophil cytoplasmic autoantibody-associated vasculitis.

C. Kallenberg, P. Limburg, C. Stegeman, 2002, Autoimmunity reviews.

Activation of a Latent Epitope Causing Differential Binding of Anti-Neutrophil Cytoplasmic Antibodies to Proteinase 3

P. Merkel, J. Stone, C. Kallenberg, 2019, bioRxiv.

Pharmacokinetics of rituximab and clinical outcomes in patients with anti-neutrophil cytoplasmic antibody associated vasculitis

D. Schroeder, P. Merkel, J. Stone, 2018, Rheumatology.

Genetic loci of Staphylococcus aureus associated with anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides

M. D. de Goffau, C. Kallenberg, J. V. van Dijl, 2017, Scientific Reports.

Are cytokines and chemokines suitable biomarkers for Takayasu arteritis?

C. Kallenberg, E. Brouwer, W. Abdulahad, 2017, Autoimmunity reviews.

Toll-like receptor 9 activation enhances B cell activating factor and interleukin-21 induced anti-proteinase 3 autoantibody production in vitro.

C. Kallenberg, P. Heeringa, W. Abdulahad, 2016, Rheumatology.

Emerging role of high mobility group box 1 in ANCA-associated vasculitis.

Min Chen, Ming‐hui Zhao, C. Kallenberg, 2015, Autoimmunity reviews.

Is B-cell depletion first choice in antineutrophil cytoplasmic antibody-associated vasculitis?

C. Kallenberg, 2014, Current opinion in rheumatology.

Infectious triggers for vasculitis

C. Kallenberg, P. Heeringa, M. V. van Timmeren, 2014, Current opinion in rheumatology.

Altered B cell balance, but unaffected B cell capacity to limit monocyte activation in anti-neutrophil cytoplasmic antibody-associated vasculitis in remission.

C. Kallenberg, P. Heeringa, W. Abdulahad, 2014, Rheumatology.

Differential Expression of Granulopoiesis Related Genes in Neutrophil Subsets Distinguished by Membrane Expression of CD177

C. Kallenberg, J. Westra, P. Heeringa, 2011, PloS one.

Granulomatosis with polyangiitis (Wegener's): An alternative name for Wegener's granulomatosis

P. Merkel, C. Kallenberg, E. Matteson, 2011, Annals of the rheumatic diseases.

Antibodies Against C1q

C. Kallenberg, K. Leeuw, 2019, Dubois' Lupus Erythematosus and Related Syndromes.

Urine levels of HMGB1 in Systemic Lupus Erythematosus patients with and without renal manifestations

M. V. van Dijk, C. Kallenberg, P. Limburg, 2012, Arthritis Research & Therapy.

The environment, geoepidemiology and ANCA-associated vasculitides.

Min Chen, C. Kallenberg, 2010, Autoimmunity reviews.

Impact of Serum High Mobility Group Box 1 and Soluble Receptor for Advanced Glycation End-Products on Subclinical Atherosclerosis in Patients with Granulomatosis with Polyangiitis

C. Kallenberg, P. Limburg, M. Bijl, 2014, PloS one.

Membrane-bound proteinase 3 and its receptors: relevance for the pathogenesis of Wegener's Granulomatosis.

C. Kallenberg, J. Westra, N. Hu, 2009, Autoimmunity reviews.

Do apoptotic cells accumulate in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation? Comment on the article by Kuhn et al.

C. Kallenberg, E. Reefman, P. Limburg, 2006, Arthritis and rheumatism.

No effects of bosentan on microvasculature in patients with limited cutaneous systemic sclerosis

A. Smit, C. Kallenberg, H. Bootsma, 2009, Clinical Rheumatology.

Higher anti‐heparan sulphate reactivity during systemic lupus erythematosus (SLE) disease exacerbations with renal manifestations; a long term prospective analysis

C. Kallenberg, C. Kramers, J. Berden, 1993, Clinical and experimental immunology.

Diversity of PR3-ANCA Epitope Specificity in Wegener's Granulomatosis. Analysis Using the Biosensor Technology

C. Kallenberg, P. Limburg, C. Stegeman, 2003, Journal of Clinical Immunology.

CHAPTER 6 Functional defect of circulating regulatory CD 4 + T-cells in patients with Wegener ’ s granulomatosis in remission

C. Kallenberg, P. Limburg, W. Abdulahad, 2018 .

Review: What Is the Current Evidence for Disease Subsets in Giant Cell Arteritis?

C. Kallenberg, P. Heeringa, A. Boots, 2018, Arthritis & rheumatology.

Novel therapies for anti-neutrophil cytoplasmic antibody-associated vasculitis

C. Kallenberg, J. C. Cohen Tervaert, C. Stegeman, 2001, Current opinion in nephrology and hypertension.

Autoantibodies vex the vasculature

C. Kallenberg, P. Heeringa, C. Stegeman, 2008, Nature Medicine.

The prototypic tissue pentraxin PTX3, in contrast to the short pentraxin serum amyloid P, inhibits phagocytosis of late apoptotic neutrophils by macrophages.

C. Kallenberg, A. Mantovani, P. Limburg, 2004, Arthritis and rheumatism.

Role for CaMKII Inhibition in Rheumatoid Arthritis

C. Kallenberg, M. V. van Leeuwen, P. Limburg, 2009, Annals of the New York Academy of Sciences.

Association of small life events with self reports of tic severity in pediatric and adult tic disorder patients: a prospective longitudinal study.

C. Kallenberg, P. Hoekstra, R. Minderaa, 2004, The Journal of clinical psychiatry.

Neutrophil‐activating potential of antineutrophil cytoplasm autoantibodies

C. Kallenberg, P. Limburg, Agnieszka A Rarok, 2003, Journal of leukocyte biology.

Plasma kynurenine and related measures in tic disorder patients

C. Kallenberg, P. Hoekstra, R. Minderaa, 2007, European Child & Adolescent Psychiatry.

Interstitial lung disease and myositis in a patient with simultaneously occurring sarcoidosis and scleroderma.

D. Postma, C. Kallenberg, H. Groen, 1993, Chest.

Complement is crucial in the pathogenesis of ANCA-associated vasculitis.

C. Kallenberg, P. Heeringa, 2013, Kidney international.

C5a primes neutrophils for ANCA-mediated activation: role of P38 mitogen-activated protein kinase

Min Chen, C. Kallenberg, P. Heeringa, 2009 .

Re-evaluation of the histopathologic classification of ANCA-associated glomerulonephritis: a study of 121 patients in a single center.

Min Chen, Ming‐hui Zhao, C. Kallenberg, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Evolving concepts in pathogenesis and treatment of ANCA‐associated systemic vasculitides

C. Kallenberg, Ming-hui Zhao, 2009, Nephrology.

Bacterial infections in Wegener's granulomatosis: mechanisms potentially involved in autoimmune pathogenesis

C. Kallenberg, P. Heeringa, H. Tadema, 2011, Current opinion in rheumatology.

University of Groningen Differential expression of granulopoiesis related genes in neutrophil subsets distinguished by membrane expression of CD177 Hu,

C. Kallenberg, J. Westra, P. Heeringa, 2014 .

T cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis (WG)

C. Kallenberg, P. Limburg, E. Brouwer, 1994, Clinical and experimental immunology.

Podocyte expression of MHC class I and II and intercellular adhesion molecule‐1 (ICAM‐1) in experimental pauci‐immune crescentic glomerulonephritis

C. Kallenberg, P. Heeringa, A. Chand, 1994, Clinical and experimental immunology.

Bacterial DNA motifs trigger ANCA production in ANCA-associated vasculitis in remission.

C. Kallenberg, P. Heeringa, W. Abdulahad, 2011, Rheumatology.

Serum Biomarkers of Disease Activity in Longitudinal Assessment of Patients with ANCA‐Associated Vasculitis

P. Merkel, J. Stone, C. Kallenberg, 2021, ACR open rheumatology.

Review : Serological markers of disease activity in systemic lupus erythematosus

C. Kallenberg, P. Limburg, P. Spronk, 1995, Lupus.

CHAPTER 2 CD 4-positive effector memory T-cells participate in disease expression in ANCA-associated vasculitis

C. Kallenberg, P. Limburg, W. Abdulahad, 2019 .

Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide.

D. Postma, C. Kallenberg, H. Bootsma, 1993, The Journal of rheumatology.

Clinical associations of antiribonucleoprotein antibodies in patients with systemic lupus erythematosus.

C. Kallenberg, P. Limburg, H. Groen, 1990, Seminars in arthritis and rheumatism.

What have we learned from clinical trials in primary Sjögren's syndrome about pathogenesis?

A. Vissink, C. Kallenberg, H. Bootsma, 2011, Arthritis research & therapy.

Inflammatory clearance of apoptotic cells after UVB challenge

C. Kallenberg, E. Reefman, P. Limburg, 2007, Autoimmunity.

Autoantibody Standardization in the Netherlands

C. Kallenberg, P. Limburg, H. Hooijkaas, 2009, Annals of the New York Academy of Sciences.

The Effect of Two Different Dosages of Intravenous Immunoglobulin on the Incidence of Recurrent Infections in Patients with Primary Hypogammaglobulinemia

C. Kallenberg, J. V. D. van der Meer, P. Strengers, 2001, Annals of Internal Medicine.

The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomized, double-blind, multicenter crossover trial.

C. Kallenberg, J. V. D. van der Meer, J. V. van Dissel, 2001, Annals of internal medicine.

B-cell-targeted therapy in rheumatic diseases

C. Kallenberg, A. Risselada, 2006 .

Therapy-resistent lupus skin disease successfully treated with rituximab.

C. Kallenberg, C. Kallenberg, A. Risselada, 2006, Rheumatology.

Staphylococcal acid phosphatase binds to endothelial cells via charge interaction; a pathogenic role in Wegener’s granulomatosis?

R. van Wijk, C. Kallenberg, P. Limburg, 2000, Clinical and experimental immunology.

Influenza vaccination in systemic lupus erythematosus: safe and protective?

C. Kallenberg, M. Bijl, A. Huckriede, 2007, Autoimmunity reviews.

Baseline predictors of response to TNF-&agr; blocking therapy in ankylosing spondylitis

C. Kallenberg, E. Brouwer, S. Arends, 2012, Current opinion in rheumatology.

Increased expression of costimulatory markers CD134 and CD80 on IL-17 producing T-cells in patients with systemic lupus erythematosus

C. Kallenberg, A. Kribben, T. Feldkamp, 2017 .

L3. Are mononuclear cells predominant actors of endothelial damage in vasculitis?

C. Kallenberg, W. Abdulahad, A. D. de Souza, 2013, Presse medicale.

Increased expression of costimulatory markers CD134 and CD80 on interleukin-17 producing T cells in patients with systemic lupus erythematosus

C. Kallenberg, A. Kribben, T. Feldkamp, 2010, Arthritis research & therapy.

B-cell populations and sub-populations in Sjögren's syndrome.

C. Kallenberg, N. Bos, Nishath Hamza, 2012, Presse medicale.

Activation, Apoptosis, and Clearance of Neutrophils in Wegener's Granulomatosis

C. Kallenberg, P. Limburg, A. Rossum, 2005, Annals of the New York Academy of Sciences.

Quantification of Epstein-Barr virus-DNA load in lung transplant recipients: a comparison of plasma versus whole blood.

C. Kallenberg, W. van der Bij, N. Veeger, 2008, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Genetics of ANCA-associated vasculitides.

C. Kallenberg, C. Stegeman, Agnieszka A Rarok, 2002, Cleveland Clinic journal of medicine.

Current therapy of granulomatosis with polyangiitis and microscopic polyangiitis: the role of rituximab

J. Stone, C. Kallenberg, G. Appel, 2014, Journal of Nephrology.

Immune regulatory mechanisms in ANCA-associated vasculitides.

C. Kallenberg, P. Heeringa, W. Abdulahad, 2011, Autoimmunity reviews.

Experimental Therapies in Sjögren’s Syndrome

A. Vissink, C. Kallenberg, F. Spijkervet, 2011 .

The Future of Biologic Agents in the Treatment of Sjögren’s Syndrome

A. Vissink, C. Kallenberg, H. Bootsma, 2007, Clinical reviews in allergy & immunology.

Pulmonary Manifestations of Systemic Vasculitides

C. Kallenberg, W. Timens, C. Stegeman, 1998 .

Auto-antigen expression of proteinase 3 on the membrane of neutrophils is dependent on phosphatidylinositol 3-kinase and P38 MAPkinase activity

C. Kallenberg, P. Limburg, B. D. D. Meer, 2006 .

Disease Activity, ANCA-Type, and Lipid Levels in ANCA-Associated Vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2019, Arthritis & rheumatology.

Absence of Cross-Reactivity to Myeloperoxidase of Anti-Thyroid Microsomal Antibodies in Patients with Autoimmune Thyroid Diseases

C. Kallenberg, P. Limburg, T. T. Queluz, 2001, The American journal of the medical sciences.

High mobility group box 1 (HMGB1) and anti-HMGB1 antibodies and their relation to disease characteristics in systemic lupus erythematosus

C. Kallenberg, P. Limburg, M. Bijl, 2011, Arthritis research & therapy.

Human anti-neutrophil cytoplasm autoantibodies to proteinase 3 (PR3-ANCA) bind to neutrophils.

C. Kallenberg, P. Limburg, Y. M. van der Geld, 2005, Kidney international.

Epstein-Barr Virus–DNA Load Monitoring Late After Lung Transplantation: A Surrogate Marker of the Degree of Immunosuppression and a Safe Guide to Reduce Immunosuppression

C. Kallenberg, M. Erasmus, W. van der Bij, 2007, Transplantation.

Pulmonary diffusing capacity disturbances are related to nailfold capillary changes in patients with Raynaud's phenomenon with and without an underlying connective tissue disease.

C. Kallenberg, T. W. van der Mark, H. Groen, 1990, The American journal of medicine.

Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.

C. Kallenberg, T. Dougan, J. Levy, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The future of damage assessment in vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2007, The Journal of rheumatology.

CHAPTER 3 Disturbed Th 1 , Th 2 , Th 17 and Treg balance in patients with systemic lupus erythematosus

C. Kallenberg, P. Limburg, M. Bijl, 2017 .

Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7.

J. Krischer, D. Felson, P. Merkel, 2005, The Journal of rheumatology.

Serum amyloid P component binds to late apoptotic cells and mediates their uptake by monocyte-derived macrophages.

C. Kallenberg, P. Limburg, M. Bijl, 2003, Arthritis and rheumatism.

Pathogenesis of PR3-ANCA associated vasculitis.

C. Kallenberg, C. Kallenberg, 2008, Journal of autoimmunity.

Systems Biology Analysis of Sjögren’s Syndrome and MALT Lymphoma Development in Parotid Glands

A. Vissink, C. Kallenberg, Jianghuai Wang, 2008 .

The net effect of ANCA on neutrophil extracellular trap formation.

C. Kallenberg, P. Heeringa, A. Rutgers, 2018, Kidney international.

Plasma Factors in Severe Early-Onset Preeclampsia Do Not Substantially Alter Endothelial Gene Expression In Vitro

C. Kallenberg, F. Gerbens, J. Aarnoudse, 2005, The Journal of the Society for Gynecologic Investigation: JSGI.

Lack of effect of intravenous immunoglobulins on tics: a double-blind placebo-controlled study.

C. Kallenberg, P. Hoekstra, R. Minderaa, 2004, The Journal of clinical psychiatry.

A. Vissink, C. Kallenberg, F. Spijkervet, 2009 .

Autoantibodies during captopril treatment.

C. Kallenberg, 1985, Arthritis and rheumatism.

Cutaneous reactions to captopril

C. Kallenberg, A. Donker, J. Monchy, 1984, Clinical allergy.

Constitutive membrane expression of proteinase 3 (PR3) and neutrophil activation by anti‐PR3 antibodies

C. Kallenberg, P. Limburg, G. Fassina, 2004, Journal of leukocyte biology.

Membrane proteinase 3 expression on resting neutrophils as a pathogenic factor in PR3-ANCA-associated vasculitis.

C. Kallenberg, P. Limburg, C. Kallenberg, 2003, Clinical and experimental rheumatology.

Autoantibodies against glomerular endothelial cells in anti‐neutrophil cytoplasmic autoantibody‐associated systemic vasculitis

C. Kallenberg, P. Limburg, J. Westra, 2009, Nephrology.

Dying neutrophils in ANCA-associated vasculitis: good or bad guys?

C. Kallenberg, 2002, Kidney international.

Autoantibodies to myeloperoxidase: clinical and pathophysiological significance

C. Kallenberg, 1998, Journal of Molecular Medicine.

Antineutrophil Cytoplasmic Autoantibodies with Specificity for Myeloperoxidase

C. Kallenberg, 1996 .

ANCA: their clinical relevance

C. Kallenberg, 1996 .

Antineutrophil cytoplasmic antibodies (ANCA): current perspectives

C. Kallenberg, 1996 .

Antimyeloperoxidase-associated Proliferative Glomerulonephritis: An Animal Model By Elisabeth Brouwer,* Minke G. Huitema,* Pieter A. Klok,~

C. Kallenberg, J. Weening, J. Tervaert, 1993 .

Absence of In Vivo Generalized Pro-Inflammatory Endothelial Activation in Severe, Early-Onset Preeclampsia

C. Kallenberg, J. Aarnoudse, G. Molema, 2005, Journal of the Society for Gynecologic Investigation.

Is serum HMGB1 a biomarker in ANCA-associated vasculitis?

C. Kallenberg, P. Limburg, M. Bijl, 2013, Arthritis Research & Therapy.

University of Groningen Is serum HMGB 1 a biomarker in ANCA-associated vasculitis ?

C. Kallenberg, P. Limburg, M. Bijl, 2013 .

ANCA-associated vasculitis: pathogenesis revisited

C. Kallenberg, 2004 .

Standard therapeutic regimens for vasculitis

C. Kallenberg, C. Stegeman, J. Tervaert, 2001 .

Anti-myeloperoxidase antibodies in Churg-Strauss syndrome

C. Kallenberg, J. Tervaert, Cornelis Kallenberg, 1993, Journal of Neurology.

Successful treatment of ulcerating livedo reticularis with infusions of prostacyelin

A. Smit, C. Kallenberg, K. Hoogenberg, 1992, The British journal of dermatology.

Pulmonary arterial hypertension in systemic lupus erythematosus: should we bother?

C. Kallenberg, M. Bijl, H. Bootsma, 2009, Rheumatology.

Chapter 7 Plasma kynurenine and tryptophan in Tourette ’ s and chronic motor tic disorder

C. Kallenberg, P. Hoekstra, R. Minderaa, 2018 .

Serum levels of BAFF, but not APRIL, are increased after rituximab treatment in patients with primary Sjögren's syndrome: data from a placebo-controlled clinical trial

A. Vissink, C. Kallenberg, J. Burgerhof, 2012, Annals of the rheumatic diseases.

B cell reconstitution and T helper cell balance after rituximab treatment of active primary Sjögren's syndrome: a double-blind, placebo-controlled study.

A. Vissink, C. Kallenberg, F. Spijkervet, 2011, Arthritis and rheumatism.

Chapter 4 Image analysis ; a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener ’ s Granulomatosis

C. Kallenberg, J. Damoiseaux, M. Patnaik, 2018 .

Increased accumulation of advanced glycation endproducts in patients with Wegener's granulomatosis

A. Smit, C. Kallenberg, M. Bijl, 2009, Annals of the rheumatic diseases.

Recombinant proteinase 3 produced in different expression systems: recognition by anti-PR3 antibodies.

C. Kallenberg, P. Limburg, U. Specks, 2000, Journal of immunological methods.

High mobility group box 1 ( HMGB 1 ) and anti-HMGB 1 antibodies and their relation to disease characteristics in systemic lupus erythematosus

C. Kallenberg, P. Limburg, M. Bijl, 2011 .

Vasculitis and infections: Contribution to the issue of autoimmunity reviews devoted to “autoimmunity and infection”

C. Kallenberg, H. Tadema, 2008, Autoimmunity Reviews.

Rituximab versus cyclophosphamide for ANCA-associated vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2010, The New England journal of medicine.

Circulating markers of vascular injury and angiogenesis in antineutrophil cytoplasmic antibody-associated vasculitis.

J. Krischer, P. Merkel, J. Stone, 2011, Arthritis and rheumatism.

Identifying relevant determinants of in-hospital time to diagnosis for ANCA-associated vasculitis patients

H. de Ruiter, C. Kallenberg, T. Rabelink, 2022, Rheumatology advances in practice.

Factors Determining the Clinical Utility of Serial Measurements of Antineutrophil Cytoplasmic Antibodies Targeting Proteinase 3

D. Schroeder, P. Merkel, J. Stone, 2016, Arthritis & rheumatology.

Comparison of lacrimal and salivary gland involvement in Sjögren's syndrome.

A. Vissink, J. Roodenburg, C. Kallenberg, 2003, Archives of otolaryngology--head & neck surgery.

Baseline predictors of response and discontinuation of tumor necrosis factor-alpha blocking therapy in ankylosing spondylitis: a prospective longitudinal observational cohort study

C. Kallenberg, E. Brouwer, H. Groen, 2011, Arthritis research & therapy.

Acute hepatitis B in a healthcare worker: a case report of genuine vaccination failure.

C. Kallenberg, L. A. van der Waaij, J. van Steenbergen, 2009, Journal of hepatology.

Effectiveness of rituximab treatment in primary Sjögren's syndrome: a randomized, double-blind, placebo-controlled trial.

A. Vissink, C. Kallenberg, F. Spijkervet, 2010, Arthritis and rheumatism.

Association of Chronic Nasal Carriage of Staphylococcus aureus and Higher Relapse Rates in Wegener Granulomatosis

C. Kallenberg, W. Sluiter, J. Tervaert, 1994, Annals of Internal Medicine.

Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis.

L. Joosten, M. Mayes, J. Reveille, 2014, The New England journal of medicine.

Determinants of renal outcome in anti-myeloperoxidase-associated necrotizing crescentic glomerulonephritis.

C. Kallenberg, P. Limburg, P. D. de Jong, 1998, Journal of the American Society of Nephrology : JASN.

Serum proteins reflecting inflammation, injury and repair as biomarkers of disease activity in ANCA-associated vasculitis

J. Krischer, P. Merkel, J. Stone, 2011, Annals of the rheumatic diseases.

International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

Torsten Witte, Ulrich Sack, Xavier Bossuyt, 2013, Annals of the Rheumatic Diseases.

Cell-mediated immune responses to inactivated trivalent influenza-vaccination are decreased in patients with common variable immunodeficiency.

C. Kallenberg, M. Bijl, J. Westra, 2011, Clinical immunology.

Relative Contribution of Attention-Deficit Hyperactivity Disorder, Obsessive-Compulsive Disorder, and Tic Severity to Social and Behavioral Problems in Tic Disorders

J. Korf, C. Kallenberg, P. Hoekstra, 2004, Journal of developmental and behavioral pediatrics : JDBP.

Leukocyte activation in sepsis; correlations with disease state and mortality

C. Kallenberg, J. Hermans, J. Zijlstra, 2000, Intensive Care Medicine.

Lack of Association of C-C Chemokine Receptor 5 Δ32 Deletion Status with Rheumatoid Arthritis, Systemic Lupus Erythematosus, Lupus Nephritis, and Disease Severity

C. Kallenberg, G. Navis, M. Bijl, 2010, The Journal of Rheumatology.

Molecular genetic analyses of human NKG2C (KLRC2) gene deletion.

C. Kallenberg, K. Tokunaga, K. Hikami, 2004, International immunology.

Hypoxia-inducible factor-1 as regulator of angiogenesis in rheumatoid arthritis - therapeutic implications.

C. Kallenberg, G. Molema, J. Westra, 2010, Current medicinal chemistry.

Systems analysis of primary Sjögren's syndrome pathogenesis in salivary glands identifies shared pathways in human and a mouse model

Steve Horvath, Arjan Vissink, Hendrika Bootsma, 2012, Arthritis Research & Therapy.

Key advances in the clinical approach to ANCA-associated vasculitis

C. Kallenberg, 2014, Nature Reviews Rheumatology.

Fc receptor-like 5 and anti-CD20 treatment response in granulomatosis with polyangiitis and microscopic polyangiitis

P. Merkel, J. Stone, C. Kallenberg, 2020, JCI insight.

Increased seroreactivity in tic disorder patients to a 60 kDa protein band from a neuronal cell line

J. Korf, C. Kallenberg, P. Hoekstra, 2003, Journal of Neuroimmunology.

P. Merkel, J. Stone, C. Kallenberg, 2015, Arthritis & rheumatology.

FoxP3+ CD4+ T cells in systemic autoimmune diseases: the delicate balance between true regulatory T cells and effector Th-17 cells.

C. Kallenberg, A. Boots, W. Abdulahad, 2011, Rheumatology.

Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases

C. Kallenberg, P. Limburg, J. Kleibeuker, 1993, Hepatology.

High mobility group box 1 serum levels are increased in Behçet's disease, but not associated with disease activity or disease manifestations.

C. Kallenberg, M. Bijl, J. Westra, 2015, Rheumatology.

Peripheral CD5+ B Cells in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

P. Merkel, J. Stone, C. Kallenberg, 2015, Arthritis & rheumatology.

FSAP‐mediated nucleosome release from late apoptotic cells is inhibited by autoantibodies present in SLE

C. Kallenberg, J. Westra, L. Aarden, 2016, European journal of immunology.

Role of the Fcgamma receptor IIA polymorphism in the antiphospholipid syndrome: an international meta-analysis.

J. Ioannidis, C. Kallenberg, J. Piette, 2003, Arthritis and rheumatism.

M2 macrophage is the predominant phenotype in airways inflammatory lesions in patients with granulomatosis with polyangiitis

C. Kallenberg, J. Westra, P. Heeringa, 2017, Arthritis Research & Therapy.

Humoral responses after influenza vaccination are severely reduced in patients with rheumatoid arthritis treated with rituximab.

C. Kallenberg, M. V. van Leeuwen, M. Bijl, 2010, Arthritis and rheumatism.

Endothelial Progenitor Cells and cardiovascular risk in patients with Early Rheumatoid Arthritis

C. Kallenberg, M. Bijl, J. Westra, 2014 .

The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis

C. Kallenberg, G. Bruyn, E. Brouwer, 2010, Osteoporosis International.

Renal expression of matrix metalloproteinases in human ANCA-associated glomerulonephritis.

C. Kallenberg, H. van Goor, R. Hanemaaijer, 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

The effect of three years of TNF alpha blocking therapy on markers of bone turnover and their predictive value for treatment discontinuation in patients with ankylosing spondylitis: a prospective longitudinal observational cohort study

C. Kallenberg, E. Brouwer, H. Groen, 2012, Arthritis Research & Therapy.

The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2018, Clinical journal of the American Society of Nephrology : CJASN.

Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis

C. Kallenberg, M. Bijl, J. Westra, 2009, Annals of the rheumatic diseases.

Association of poly(ADP-ribose) polymerase 1 and a novel candidate locus, LOC127086, with systemic lupus erythematosus

C. Kallenberg, G. T. te Meerman, I. Nolte, 2007, Annals of the rheumatic diseases.

Skewed distribution of Th17 lymphocytes in patients with Wegener's granulomatosis in remission.

C. Kallenberg, P. Limburg, W. Abdulahad, 2008, Arthritis and rheumatism.

Association of common cold with exacerbations in pediatric but not adult patients with tic disorder: a prospective longitudinal study.

C. Kallenberg, P. Hoekstra, R. Minderaa, 2005, Journal of child and adolescent psychopharmacology.

Leukocyte Cell Adhesion Molecules in Vasculitis

C. Kallenberg, J. Tervaert, 2001 .

Does reduction of disease activity improve early markers of cardiovascular disease in newly diagnosed rheumatoid arthritis patients?

A. Smit, C. Kallenberg, M. Bijl, 2015, Rheumatology.

University of Groningen Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors Hettema,

A. Smit, C. Kallenberg, H. Bootsma, 2015 .

Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease

A. Smit, C. Kallenberg, M. Bijl, 2011, Arthritis research & therapy.

Small artery elasticity is decreased in patients with systemic lupus erythematosus without increased intima media thickness

A. Smit, A. V. van Roon, C. Kallenberg, 2010, Arthritis research & therapy.

Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors

A. Smit, C. Kallenberg, H. Bootsma, 2008, Arthritis research & therapy.

Enhanced endothelium-dependent microvascular responses in patients with Wegener's granulomatosis.

A. Smit, C. Kallenberg, M. Bijl, 2007, The Journal of rheumatology.

Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus

C. Kallenberg, M. Harmsen, M. Bijl, 2007, Arthritis research & therapy.

Accelerated atherosclerosis in patients with Wegener’s granulomatosis

A. Smit, C. Kallenberg, M. Bijl, 2004, Annals of the rheumatic diseases.

Studies of cell-mediated immune responses to influenza vaccination in systemic lupus erythematosus.

C. Kallenberg, M. Bijl, J. Westra, 2009, Arthritis and rheumatism.

A. Vissink, C. Kallenberg, F. Spijkervet, 2009, Rheumatology.

Dysregulated neutrophil--endothelial interaction in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitides: implications for pathogenesis and disease intervention.

C. Kallenberg, J. Westra, N. Hu, 2011, Autoimmunity reviews.

Chapter VI Anti-CD 3-induced and anti-Fas-induced apoptosis in systemic lupus erythematosus ( SLE )

C. Kallenberg, P. Limburg, M. Bijl, 2001 .

Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement.

P. Merkel, J. Stone, C. Kallenberg, 2015, Journal of the American Society of Nephrology : JASN.

Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.

C. Kallenberg, M. Bijl, J. Westra, 2009, Rheumatology.

Commentary Staphylococcus aureus and Wegener ’ s granulomatosis

C. Kallenberg, E. Popa, C. Stegeman, 2015 .

Extended Follow-up of Treatment with Rituximab Versus Cyclophosphamide for Remission-Induction of ANCA-Associated Vasculitis : Which Subsets Are At Greatest Risk for Flare?

P. Merkel, J. Stone, C. Kallenberg, 2011 .

EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis

Shigeto Kobayashi, John McLaren, David Jayne, 2010, Annals of the rheumatic diseases.

Development and standardization of solid phase assays for the detection of anti-neutrophil cytoplasmic antibodies (ANCA). A report on the second phase of an international cooperative study on the standardization of ANCA assays.

C. Kallenberg, A. Wiik, M. Daha, 1996, Journal of immunological methods.

Antineutrophil cytoplasmic antibodies (ANCA) and vasculitis

C. Kallenberg, 1990, Clinical Rheumatology.

Plasma levels of soluble IL-2R, soluble CD30, IL-10 and BAFF during follow-up in PR3-ANCA-associated vasculitis: associations with disease activity and relapse

C. Kallenberg, C. Stegeman, M. Huitema, 2006 .

Prevention of relapses in antineutrophil cytoplasmic antibody associated vasculitis by treatment based on autoantibody levels as detected by solid phase assay: a preliminary report

C. Kallenberg, P. Limburg, J. Hermans, 2001 .

Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

M. Konig, P. Merkel, J. Stone, 2022, Arthritis & rheumatology.

The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis.

D. Schroeder, P. Merkel, J. Stone, 2019, Journal of autoimmunity.

Anti-neutrophil cytoplasmic autoantibody pathogenicity revisited: pathogenic versus non-pathogenic anti-neutrophil cytoplasmic autoantibody.

C. Kallenberg, A. Rutgers, J. Land, 2014, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Native and recombinant proteins to analyze auto-antibodies to myeloperoxidase in pauci-immune crescentic glomerulonephritis.

C. Kallenberg, P. Limburg, C. Stegeman, 2001, Journal of immunological methods.

CHAPTER 9 ENHANCED ENDOTHELIUM-DEPENDENT MICROVASCULAR RESPONSES IN PATIENTS WITH WEGENER ’ S GRANULOMATOSIS

A. Smit, C. Kallenberg, M. Bijl, 2019 .

CHAPTER 8 PROGRESSION OF ATHEROSCLEROSIS IN PATIENTS WITH WEGENER ’ S GRANULOMATOSIS : A LONG-TERM FOLLOW-UP STUDY

A. Smit, C. Kallenberg, M. Bijl, 2019 .

Patients with Wegener's granulomatosis: a long-term follow-up study.

A. Smit, C. Kallenberg, M. Bijl, 2010, Clinical and experimental rheumatology.

Interstitial Immunostaining and Renal Outcomes in Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis

P. Merkel, J. Stone, C. Kallenberg, 2017, American Journal of Nephrology.

The BVAS is an independent predictor of cardiovascular events and cardiovascular disease-related mortality in patients with ANCA-associated vasculitis: A study of 504 cases in a single Chinese center.

Min Chen, C. Kallenberg, Zhi-Ying Li, 2018, Seminars in arthritis and rheumatism.

The Fc gamma RIIIA-158F allele is a risk factor for systemic lupus erythematosus

Dirk Roos, Masja de Haas, Kathleen E. Sullivan, 1998 .

Cytokines and soluble adhesion molecules in children and adolescents with a tic disorder

C. Kallenberg, P. Hoekstra, R. Minderaa, 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

The R-H polymorphism of FCgamma receptor IIa as a risk factor for systemic lupus erythematosus is independent of single-nucleotide polymorphisms in the interleukin-10 gene promoter.

C. Kallenberg, T. Huizinga, J. V. D. van de Winkel, 2002, Arthritis and rheumatism.

T FcRIIIA158F allele is a risk factor for systemic lupus erythematosus

M. Petri, C. Kallenberg, K. Sullivan, 1998 .

ATHEROSCLEROSIS IN PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES

C. Kallenberg, M. Bijl, K. Leeuw, 2008 .

CHAPTER 1 ACCELERATED ATHEROSCLEROSIS IN PATIENTS WITH SYSTEMIC AUTOIMMUNE DISEASES

C. Kallenberg, M. Bijl, K. Leeuw, 2008 .

Smoking and increased apoptosis in patients with systemic lupus erythematosus: comment on the article by Costenbader et al.

C. Kallenberg, P. Limburg, M. Bijl, 2004, Arthritis and rheumatism.

Reactivity against Complementary Proteinase-3 Is Not Increased in Patients with PR3-ANCA-Associated Vasculitis

C. Kallenberg, P. Heeringa, C. Stegeman, 2011, PloS one.

Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus.

A. Smit, A. V. van Roon, C. Kallenberg, 2009, Atherosclerosis.

Risk factors and early detection of atherosclerosis in rheumatoid arthritis

C. Kallenberg, M. Bijl, L. de Groot, 2010, European journal of clinical investigation.

Traditional and non-traditional risk factors contribute to the development of accelerated atherosclerosis in patients with systemic lupus erythematosus

A. Smit, C. Kallenberg, M. Bijl, 2006, Lupus.

Daily physical activity in ankylosing spondylitis: validity and reliability of the IPAQ and SQUASH and the relation with clinical assessments

C. Kallenberg, E. Brouwer, Y. Kamsma, 2013, Arthritis Research & Therapy.

Fcγ receptors in the initiation and progression of systemic lupus erythematosus

C. Kallenberg, E. Reefman, P. Limburg, 2003 .

Fluctuations in anti-nRNP levels in patients with mixed connective tissue disease are related to disease activity as part of a polyclonal B cell response.

C. Kallenberg, M. V. van Leeuwen, P. Limburg, 1986, Annals of the rheumatic diseases.

Disease Activity, Glucocorticoid Exposure, and Rituximab Determine Body Composition Changes during Induction Treatment of ANCA‐Associated Vasculitis

C. Kallenberg, Hyon K. Choi, P. Monach, 2016 .

Autoantibodies against Protective Molecules—C1q, C‐Reactive Protein, Serum Amyloid P, Mannose‐Binding Lectin, and Apolipoprotein A1

C. Kallenberg, Y. Shoenfeld, B. Gilburd, 2007, Annals of the New York Academy of Sciences.

Anti-C1q autoantibodies.

C. Kallenberg, 2008, Autoimmunity reviews.

Combined brain and heart magnetic resonance imaging in systemic vasculitides: fiction or real need?

C. Kallenberg, H. Lamb, G. Kitas, 2018, Clinical and experimental rheumatology.

Anti-neutrophil cytoplasm autoantibodies (ANCA) in autoimmune liver diseases.

C. Kallenberg, C. Roozendaal, 1999, Hepato-gastroenterology.

Effect of Disease Activity, Glucocorticoid Exposure, and Rituximab on Body Composition During Induction Treatment of Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

P. Merkel, J. Stone, C. Kallenberg, 2017, Arthritis care & research.

Anti‐neutrophil cytoplasmic antibodies and the endothelium: many ways to vasculitis

C. Kallenberg, C. Kallenberg, 1997, European journal of clinical investigation.

Increased Expression of Toll-Like Receptors by Monocytes and Natural Killer Cells in ANCA-Associated Vasculitis

C. Kallenberg, P. Heeringa, W. Abdulahad, 2011, PloS one.

B cell phenotype and function in granulomatosis with polyangiitis Land

C. Kallenberg, 2016 .

antibodies antigens referred to as anti-nuclear assessment of autoantibodies to cellular International recommendations for the

C. Kallenberg, N. Agmon-Levin, J. Damoiseaux, 2013 .

The Pharmacogenomic Association of Fcγ Receptors and Cytochrome P450 Enzymes With Response to Rituximab or Cyclophosphamide Treatment in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis

B. Rovin, P. Merkel, J. Stone, 2016, Arthritis & rheumatology.

Oral and ocular manifestations in Sjögren's syndrome.

Cees G M Kallenberg, Wouter W I Kalk, Khaled Mansour, 2002, The Journal of rheumatology.

Skin Autofluorescence, as Marker of Accumulation of Advanced Glycation Endproducts and of Cumulative Metabolic Stress, Is Not Increased in Patients with Systemic Sclerosis

A. Smit, C. Kallenberg, R. Graaff, 2011, International journal of rheumatology.

Activation of a Latent Epitope Causing Differential Binding of Anti-Neutrophil Cytoplasmic Antibodies to Proteinase 3

P. Merkel, J. Stone, C. Kallenberg, 2022, bioRxiv.

Advances in pathogenesis and treatment of ANCA-associated vasculitis.

C. Kallenberg, 2014, Discover medicine.

Patients' perceptions of the effects of systemic lupus erythematosus on health, function, income, and interpersonal relationships: a comparison with Wegener's granulomatosis.

C. Kallenberg, M. Bijl, G. Hoffman, 2002, Arthritis and rheumatism.

Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis (GPA)

C. Kallenberg, P. Limburg, P. Heeringa, 2013, Arthritis Research & Therapy.

Combined Brain/Heart Magnetic Resonance Imaging in Systemic Lupus Erythematosus

C. Kallenberg, G. Kitas, G. Kolovou, 2020, Current cardiology reviews.

Treatment approaches in primary Sjogren syndrome.

A. Vissink, C. Kallenberg, H. Bootsma, 2010, JAMA.

Low anti-staphylococcal IgG responses in granulomatosis with polyangiitis patients despite long-term Staphylococcus aureus exposure

M. D. de Goffau, C. Kallenberg, J. V. van Dijl, 2015, Scientific Reports.

The Fc gammaRIIIA-158F allele is a risk factor for systemic lupus erythematosus.

M. Petri, C. Kallenberg, M. Bijl, 1998, Arthritis and rheumatism.

Site-Specific Inhibition of Glomerulonephritis Progression by Targeted Delivery of Dexamethasone to Glomerular Endothelium

C. Kallenberg, J. Kamps, G. Molema, 2007, Molecular Pharmacology.

How to assess treatment efficacy in Sjögren's syndrome?

A. Vissink, C. Kallenberg, H. Bootsma, 2012, Current opinion in rheumatology.

Antinuclear and antinative DNA antibodies during captopril treatment.

A. Smit, C. Kallenberg, T. The, 2009, Acta medica Scandinavica.

Is disturbed clearance of apoptotic keratinocytes responsible for UVB-induced inflammatory skin lesions in systemic lupus erythematosus?

C. Kallenberg, E. Reefman, P. Limburg, 2006, Arthritis research & therapy.

Rituximab treatment in primary Sjogren's syndrome : A double-blind placebo controlled trial

A. Vissink, C. Kallenberg, F. Spijkervet, 2008 .

CHAPTER 6 REDUCED NUMBER AND IMPAIRED FUNCTION OF CIRCULATING PROGENITOR CELLS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

C. Kallenberg, M. Harmsen, M. Bijl, 2019 .

Serum MMP-3 Level as a Biomarker for Monitoring and Predicting Response to Etanercept Treatment in Ankylosing Spondylitis

C. Kallenberg, P. Limburg, E. Brouwer, 2011, The Journal of Rheumatology.

Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis

P. Merkel, J. Stone, C. Kallenberg, 2021, JCI insight.

Overlapping syndromes, undifferentiated connective tissue disease, and other fibrosing conditions

C. Kallenberg, 1992, Current opinion in rheumatology.

Urinary matrix metalloproteinases reflect renal damage in anti-neutrophil cytoplasm autoantibody-associated vasculitis.

C. Kallenberg, H. van Goor, R. Hanemaaijer, 2007, American journal of physiology. Renal physiology.

EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs

J. Ioannidis, I. Bruce, M. van Buchem, 2010, Annals of the rheumatic diseases.

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

J. Ioannidis, C. Gordon, D. Isenberg, 2007, Annals of the rheumatic diseases.

Accumulation of advanced glycation endproducts in patients with systemic lupus erythematosus.

A. Smit, C. Kallenberg, R. Graaff, 2006, Rheumatology.

Refractory disease in autoimmune diseases.

C. Kallenberg, Y. Shoenfeld, C. Vasconcelos, 2011, Autoimmunity reviews.

Patients with humoral primary immunodeficiency do not develop protective anti-influenza antibody titers after vaccination with trivalent subunit influenza vaccine.

C. Kallenberg, M. Bijl, J. Westra, 2010, Clinical immunology.

Expression of Class II-MHC Antigens on Alveolar and Bronchiolar Epithelial Cells in Fibrosing Alveolitis

C. Kallenberg, F. Beaumont, L. Ley, 1986 .

CHAPTER 7 ACCELERATED ATHEROSCLEROSIS IN PATIENTS WITH WEGENER ’ S GRANULOMATOSIS

A. Smit, C. Kallenberg, M. Bijl, 2019 .

Co-expression of CD177 and membrane proteinase 3 on neutrophils in ANCA-associated vasculitis: Anti-PR3 mediated neutrophil activation is independent of CD177 expression

C. Kallenberg, P. Limburg, M. Bijl, 2008 .

Progression and treatment evaluation in diseases affecting salivary glands

A. Vissink, C. Kallenberg, J. Meijer, 2010 .

EULAR recommendations for the management of primary small and medium vessel vasculitis

H. Raspe, P. Merkel, C. Kallenberg, 2008, Annals of the Rheumatic Diseases.

Nomenclature of systemic vasculitides. Proposal of an international consensus conference.

R J Falk, J C Jennette, G G Hunder, 1994, Arthritis and rheumatism.

053. CLINICAL UTILITY OF SERIAL MEASUREMENTS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES TARGETING PROTEINASE 3 IN ANCA-ASSOCIATED VASCULITIS

D. Schroeder, P. Merkel, J. Stone, 2019, Rheumatology.

Lupus Erythematosus ( SLE ) : relation to lymphocyte activation and disease activity

C. Kallenberg, P. Limburg, M. Bijl, 2001 .

Vasculitis syndromes: Peripheral neuropathy in AAV—when vasculitis hits a nerve

C. Kallenberg, A. Rutgers, 2012, Nature Reviews Rheumatology.

Antimyeloperoxidase-associated proliferative glomerulonephritis: an animal model

C. Kallenberg, E. Brouwer, J. Weening, 1993, The Journal of experimental medicine.

Are antineutrophil cytoplasmic antibody-associated vasculitides pauci-immune?

C. Kallenberg, C. Kallenberg, J. Tervaert, 2001, Rheumatic diseases clinics of North America.

Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases

C. Kallenberg, P. Limburg, J. Kleibeuker, 1993, Hepatology.

Patients with systemic lupus erythematosus with high plasma levels of sFas risk relapse.

C. Kallenberg, M. Bijl, A. Creasy, 1999, The Journal of rheumatology.

Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases.

R. van Wijk, C. Kallenberg, P. Limburg, 2000, Journal of hepatology.

Anti-neutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential.

C. Kallenberg, E. Brouwer, J. Weening, 1994, Kidney international.

Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders.

C. Kallenberg, C. Kallenberg, J. Tervaert, 1992, The American journal of medicine.

Association of autoantibodies to myeloperoxidase with different forms of vasculitis.

C. Kallenberg, R. Goldschmeding, P. Limburg, 2010, Arthritis and rheumatism.

Association between active Wegener's granulomatosis and anticytoplasmic antibodies.

C. Kallenberg, A. Fauci, J. Velosa, 1989, Archives of internal medicine.

Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis

J. Krischer, P. Merkel, J. Stone, 2008, Annals of the rheumatic diseases.

Neutrophil cytoplasmic autoantibodies after liver transplantation in patients with primary sclerosing cholangitis.

C. Kallenberg, A. Gouw, A. Mulder, 1993, Journal of hepatology.

Risk of relapse of ANCA-associated vasculitis among patients homozygous for the proteinase 3 gene Val119Ile polymorphism

P. Merkel, C. Kallenberg, M. Prunotto, 2023, RMD Open.

EULAR recommendations for the management of large vessel vasculitis

H. Raspe, P. Merkel, C. Kallenberg, 2008, Annals of the rheumatic diseases.

Is Tourette's syndrome an autoimmune disease?

J. Korf, C. Kallenberg, P. Hoekstra, 2002, Molecular Psychiatry.

Anca associated vasculitis

C. Kallenberg, U. Specks, K. Keogh, 2017 .

Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting.

C. Kallenberg, W. V. van Venrooij, W. Venrooij, 1988, Annals of the rheumatic diseases.

Fcgamma receptor polymorphisms in Wegener's granulomatosis: risk factors for disease relapse.

C. Kallenberg, W. Sluiter, C. Kallenberg, 1999, Arthritis and rheumatism.

Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren's syndrome.

A. Vissink, J. Roodenburg, C. Kallenberg, 2007, Rheumatology.

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus

J. Ioannidis, C. Gordon, D. Isenberg, 2008, Annals of the rheumatic diseases.

Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis.

C. Kallenberg, P. Heeringa, E. Brouwer, 1998, Kidney international.

Occurrence of autoantibodies to human leucocyte elastase in Wegener's granulomatosis and other inflammatory disorders.

C. Kallenberg, C. Kallenberg, C. Stegeman, 1993, Annals of the rheumatic diseases.

Accumulation of Advanced Glycation Endproducts in Patients with Systemic Lupus Erythematosus

A. Smit, C. Kallenberg, R. Graaff, 2022 .

Inflammation in autoimmunity: receptors for IgG revisited.

C. Kallenberg, C. Kallenberg, J. V. D. van de Winkel, 2001, Trends in immunology.

Fcgamma receptors in the initiation and progression of systemic lupus erythematosus.

C. Kallenberg, E. Reefman, P. Limburg, 2003, Immunology and cell biology.

Levels of soluble VCAM‐1, soluble ICAM‐1, and soluble E‐selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study

C. Kallenberg, P. Limburg, H. Bootsma, 1994, Clinical and experimental immunology.

Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: correlates with decreased serum levels of complement

C. Kallenberg, E. Reefman, P. Limburg, 2005, Annals of the rheumatic diseases.

New insights into the pathogenesis of systemic lupus erythematosus (SLE): the role of apoptosis.

C. Kallenberg, P. Limburg, M. Bijl, 2001, The Netherlands journal of medicine.

Vaccination in adult patients with auto-immune inflammatory rheumatic diseases: a systematic literature review for the European League Against Rheumatism evidence-based recommendations for vaccination in adult patients with auto-immune inflammatory rheumatic diseases.

J. Ioannidis, M. Dougados, C. Kallenberg, 2011, Autoimmunity reviews.

Detection of autoantibodies against myeloid lysosomal enzymes: a useful adjunct to classification of patients with biopsy-proven necrotizing arteritis.

C. Kallenberg, P. Limburg, T. The, 1991, The American journal of medicine.

Autoantibodies to myeloperoxidase aggravate mild anti-glomerular-basement-membrane-mediated glomerular injury in the rat.

C. Kallenberg, P. Heeringa, J. van den Born, 1996, The American journal of pathology.

Current and future challenges in primary Sjögren's syndrome.

A. Vissink, C. Kallenberg, D. Wong, 2012, Current pharmaceutical biotechnology.

Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients.

C. Kallenberg, A. Duits, H. Bootsma, 1995, Arthritis and rheumatism.

Differential B- and T-cell activation in Wegener's granulomatosis.

C. Kallenberg, E. Popa, C. Kallenberg, 1999, The Journal of allergy and clinical immunology.

Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis

C. Kallenberg, J. Savige, D. Blockmans, 2017 .

VALIDITY AND RELIABILITY OF THE IPAQ AND SQUASH TO ASSESS DAILY PHYSICAL ACTIVITY IN PATIENTS WITH ANKYLOSING SPONDYLITIS

C. Kallenberg, E. Brouwer, Y. Kamsma, 2012 .

Type I interferons are involved in the development of ultraviolet B-induced inflammatory skin lesions in systemic lupus erythaematosus patients

C. Kallenberg, E. Reefman, P. Limburg, 2007, Annals of the rheumatic diseases.

Systemic injection of products of activated neutrophils and H2O2 in myeloperoxidase-immunized rats leads to necrotizing vasculitis in the lungs and gut.

C. Kallenberg, P. Heeringa, C. Kallenberg, 1997, The American journal of pathology.

Anca associated vasculitis: occurrence, prediction, prevention, and outcome of relapses

C. Kallenberg, U. Specks, K. Keogh, 2001 .

Rises in anti-double stranded DNA antibody levels prior to exacerbations of systemic lupus erythematosus are not merely due to polyclonal B cell activation.

C. Kallenberg, P. Limburg, C. Kallenberg, 1991, Clinical immunology and immunopathology.

Activation, Apoptosis, and Clearance of Neutrophils in Wegener's Granulomatosis

C. Kallenberg, P. Limburg, A. Rossum, 2005, Annals of the New York Academy of Sciences.

Activation, apoptosis and clearance of neutrophils in Wegener's granulomatosis

Rossum, C. Kallenberg, P. Rovere-Querini, 2005 .

Pathogenesis and treatment of ANCA-associated vasculitides.

C. Kallenberg, 2015, Clinical and experimental rheumatology.

B-cell therapy in antineutrophil cytoplasmic antibody-associated vasculitis.

C. Kallenberg, T. Hauser, 2015, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Complement Activation Is Involved in Renal Damage in Human Antineutrophil Cytoplasmic Autoantibody Associated Pauci-Immune Vasculitis

Min Chen, C. Kallenberg, P. Heeringa, 2009, Journal of Clinical Immunology.

The role of effector T-cells in the pathogenesis op lupus nephritis

C. Kallenberg, T. Feldkamp, Xin Cai, 2011 .

B cell phenotype and function in granulomatosis with polyangiitis Land

C. Kallenberg, 2016 .

Neutrophil activation in vitro and in vivo in Wegener's granulomatosis.

C. Kallenberg, P. Heeringa, H. van Goor, 1994, Kidney international.

In vitro neutrophil activation by antibodies to proteinase 3 and myeloperoxidase from patients with crescentic glomerulonephritis.

C. Kallenberg, P. Limburg, C. Franssen, 1999, Journal of the American Society of Nephrology : JASN.

Complement is crucial in the pathogenesis of ANCA-associated vasculitis.

C. Kallenberg, P. Heeringa, 2013, Kidney international.

Pathogenetic and clinical aspects of ANCA-associated vasculitis

C. Kallenberg, Min Chen, Clin Exp Rheumatol, 2009 .

Antineutrophil cytoplasmic antibodies to proteinase 3 in Wegener's granulomatosis: epitope analysis using synthetic peptides.

C. Kallenberg, P. Limburg, R. van der Zee, 2001, Kidney international.

European Attempts to Set Guidelines for Improving Diagnostics of Autoimmune Rheumatic Disorders

C. Kallenberg, J. Piette, A. Wiik, 2006, Lupus.

Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis

C. Kallenberg, D. Blockmans, R. Sinico, 2017 .

Efficacy of remission-induction regimens for ANCA-associated vasculitis.

C. Kallenberg, L. Viviano, B. Fessler, 2013, The New England journal of medicine.

Pathogenesis of ANCA-associated vasculitides

C. Kallenberg, 2011, Annals of the rheumatic diseases.

Increased Expression of Toll-Like Receptors by Monocytes and Natural Killer Cells in ANCA-Associated Vasculitis

C. Kallenberg, P. Heeringa, W. Abdulahad, 2011, PloS one.

Antimyeloperoxidase-associated lung disease. An experimental model.

C. Kallenberg, P. Heeringa, E. Brouwer, 1999, American journal of respiratory and critical care medicine.

Expression of iNOS, eNOS, and peroxynitrite-modified proteins in experimental anti-myeloperoxidase associated crescentic glomerulonephritis.

C. Kallenberg, P. Heeringa, H. van Goor, 1996, Kidney international.

Min Chen, C. Kallenberg, Zhi-Ying Li, 2018, Seminars in arthritis and rheumatism.

EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics

J. Ioannidis, C. Gordon, D. Isenberg, 2007, Annals of the rheumatic diseases.

EULAR recommendations for the management of primary small and medium vessel vasculitis

H. Raspe, C. Kallenberg, David Steven Scott, 2008, Annals of the rheumatic diseases.

SYSTEMIC LUPUS ERYTHEMATOSUS ( SLE ) : the role of apoptosis

C. Kallenberg, P. Limburg, M. Bijl, 2001 .

IgG subclass distribution of autoantibodies differs between renal and extra-renal relapses in patients with systemic lupus erythematosus.

C. Kallenberg, M. Bijl, H. Bootsma, 2002, Rheumatology.

Scl-86, a marker antigen for diffuse scleroderma.

C. Kallenberg, E. Penner, L. van de Putte, 1985, The Journal of clinical investigation.

Is Wegener's granulomatosis an autoimmune disease?

C. Kallenberg, C. Savage, C. Kallenberg, 2000, Current opinion in rheumatology.

Quantitation ofantibodies tonucleoribonucleoprotein byELISA: relation between antibody levels anddisease activity inpatients withconnective tissue disease

C. Kallenberg, P. Limburg, M. H. Rijswijk, 1985 .

High mobility group box-1 (hmgb1) in systemic vasculitides

C. Kallenberg, W. Abdulahad, C. Stegeman, 2015 .

Increased Frequency of Circulating Follicular Helper T-Cells (T-FH) in Patients with Granulomatosis with Polyangiitis.

C. Kallenberg, P. Limburg, P. Heeringa, 2011 .

University of Groningen Sjogren ' s syndrome

A. Vissink, C. Kallenberg, F. Spijkervet, 2010 .

Elevated D8/17 expression on B lymphocytes, a marker of rheumatic fever, measured with flow cytometry in tic disorder patients.

J. Korf, C. Kallenberg, P. Hoekstra, 2001, The American journal of psychiatry.

Lack of endothelial nitric oxide synthase aggravates murine accelerated anti-glomerular basement membrane glomerulonephritis.

C. Kallenberg, P. Heeringa, H. van Goor, 2000, The American journal of pathology.

Outcomes of Nonsevere Relapses in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis Treated With Glucocorticoids

P. Merkel, J. Stone, C. Kallenberg, 2015, Arthritis & rheumatology.

Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody-associated vasculitis.

P. Merkel, J. Stone, C. Kallenberg, 2013, Arthritis and rheumatism.

Wegener’s granulomatosis patients show an adequate antibody response to influenza vaccination

C. Kallenberg, M. Bijl, J. Wilschut, 2008, Annals of the rheumatic diseases.

Anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver disease.

C. Kallenberg, G. Horst, J. H. Kleibeuker, 1993, Advances in Experimental Medicine and Biology.

The role of bacterial infections for the initiation and exacerbation of systemic vasculitis.

C. Kallenberg, 2004, Autoimmunity reviews.

Damage in ANCA-associated vasculitis: Preliminary evidence for the ANCA-associated vasculitis index of damage (AVID).

J. Stone, C. Kallenberg, E. Clair, 2006 .

B cell phenotype and function in granulomatosis with polyangiitis

C. Kallenberg, A. Rutgers, Judith Land, 2016 .

Image analysis: a novel approach for the quantification of antineutrophil cytoplasmic antibody levels in patients with Wegener's granulomatosis.

C. Kallenberg, J. Damoiseaux, M. Patnaik, 2003, Journal of immunological methods.

EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints

J. Ioannidis, C. Gordon, D. Isenberg, 2008, Annals of the rheumatic diseases.